Flow cytofluorometric analysis of the effects of new nitrosourea derivatives on proliferation of EMT 6 tumor cells "in vitro". 1981

M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach

Examined by flow cytofluorometric analysis, the DNA distribution of EMT 6 tumor cells was highly perturbed after one hour of in vitro incubation with: RPCNU, RFCNU, chlorozotocin (CZT) or 185 (CNCC), four new nitrosourea derivatives. After the treatment with chlorozotocin (20 micrograms/ml) and CNCC (50 micrograms/ml), most of cells were in G2 + M phase and this accumulation lasted more than 48 hours without any restoration before 72 hours. RPCNU (20 micrograms/ml) and RFCNU (50 and 65 micrograms/ml) induced and accumulation of cells in G2 + M phase during 24 hours. The normal state was regained after 48 hours. These reduced rate of progression of the cells through S phase and the G2 block observed after exposure to the new compounds, should, in part, explain their antitumoral activity.

UI MeSH Term Description Entries
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003584 Cytological Techniques Methods used to study CELLS. Cytologic Technics,Cytological Technic,Cytological Technics,Cytological Technique,Technic, Cytological,Technics, Cytological,Technique, Cytological,Techniques, Cytological,Cytologic Technic,Technic, Cytologic,Technics, Cytologic
D005470 Fluorometry An analytical method for detecting and measuring FLUORESCENCE in compounds or targets such as cells, proteins, or nucleotides, or targets previously labeled with FLUORESCENCE AGENTS. Fluorimetry,Fluorometric Analysis,Analysis, Fluorometric
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach
September 1988, Journal of reproduction and fertility,
M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach
July 1982, New York state journal of medicine,
M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach
January 1982, International journal of radiation oncology, biology, physics,
M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach
September 1976, Acta pathologica et microbiologica Scandinavica. Section A, Pathology,
M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach
August 1979, International journal of radiation oncology, biology, physics,
M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach
January 1983, Cellular and molecular biology,
M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach
January 1991, Pediatric neurology,
M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach
January 1987, Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc,
M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach
February 1982, The Journal of biological chemistry,
M N Vlaeminck, and M Collyn-d'Hooghe, and P Cappelaere, and G Biserte, and J Oiry, and J L Montero, and J L Imbach
May 1982, Cytometry,
Copied contents to your clipboard!